🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Social Prescribing to Improve Adherence and Outcomes in Women With Heart Failure

RecruitingNAAges 18 Years - anyFemaleMcGill University Health Centre/Research Institut…
NCT06628973 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Background: Heart Failure (HF) is the second most common cause of hospitalizations for women in North America. Non-adherence to guideline-directed medical therapy (GDMT) is associated with 50% of all treatment failures and high rates of hospitalizations and death. A recent Canadian study showed that adherence to three or more GDMT medications occurred in only 20% of Canadian HF patients. Despite clear guidelines on the pharmacologic management of HF and the introduction of new and effective drugs, adherence to GDMT in women with HF is low. Furthermore, the rates of hospitalizations have not improved in Canada over the last decade, and mortality in Canadian women with HF remains high. One explanation may be that social determinants of health (SDOH), which are known to be strong predictors of both adherence and adverse outcomes in HF, have not specifically been targeted to improve either a

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Women * 18 years of age or older * Documented HF of any etiology * Valid personal health identifier * Two or more points on the weighted SPARK questionnaire Exclusion Criteria: * Patients not meeting inclusion criteria * Do not take HF medications * Not residents of the province where they are being followed or who have opted out from their provincial health registry * Patients with severe cognitive impairment or other conditions that significantly impact the ability to participate in SP will also be excluded.
💊

What it tests

  • Social prescribing
📍

Where

2 sites
Research Institute of the McGill University Health Centre
Montreal, Canada
Royal Victoria Hospital
Montreal, Canada
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy